This trial is active, not recruiting.

Condition metabolic syndrome
Treatments elm group, elm classes, elm individual
Phase phase 1/phase 2
Sponsor Rush University Medical Center
Collaborator National Heart, Lung, and Blood Institute (NHLBI)
Start date July 2014
End date May 2015
Trial size 48 participants
Trial identifier NCT02233088, 11111701-CA01, R56HL118343-01A1


Approximately 24% of the US adult population meet criteria for metabolic syndrome (MetS), diagnosed by a combination of abdominal obesity, elevated blood pressure, high triglyceride and low HDL-cholesterol level, and pre-diabetes. MetS quintuples the risk of diabetes, and doubles the risk of cardiovascular disease (CVD), particularly heart failure. Lifestyle modification is the initial step of treatment, but few studies have demonstrated early and sustained efficacy in remission of MetS. Our preliminary studies of a lifestyle change program for patients with MetS included a 1-year of development of an intervention by an interdisciplinary team of experts in medicine and the behavioral sciences. The investigators then tested the efficacy of the intervention in a treatment-only, proof-of-concept study. The investigators achieved our goal of 50% MetS remission after 2 years, in a sample of 26 patients. This study is the second step of a research program testing an innovative bio-behavioral intervention aimed at remitting MetS through lifestyle intervention, by focusing on eating patterns, daily activity, and stress management. The overarching objective of this research program is to determine the efficacy of the ELM lifestyle intervention to achieve remission of MetS. This purpose of the current study is to prepare for a large, randomized, clinical trial by conducting a smaller clinical trial that examines the acceptability of the ELM intervention (ELM Group) as compared to two other intervention arms (ELM Classes, ELM Individual).

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking double blind (investigator, outcomes assessor)
Primary purpose treatment
A 6-month group lifestyle intervention, consisting of 12 weekly and 6 bi-weekly 2-hour sessions. The sessions consist of 30-min physical activity, 30-min meal demonstration, and 60-min group behavioral intervention, with a focus on experiential learning in naturalistic setting. Sessions are facilitated by dietitian/personal trainer and behavioral specialist.
elm group ELM Lifestyle Intervention
ELM participants are trained to portion their meals according to the "Perfect Plate" method, a modified version of the USDA's ChooseMyPlate.gov. The stress management focuses on mindful living, cognitive restructuring; the enhancement of positive emotions. The physical activity component focuses on reduction of sedentary activity (by increasing daily step counts) and moderate-to-vigorous physical activity.
A 6-month health education, consisting of 12 weekly and 6 bi-weekly 30-45 min sessions. The sessions consist of didactic classes, with a focus on health education curriculum. Sessions are facilitated by a health educator and medical providers.
elm classes Health Education
ELM classes will be administered through Rush Generations program and focus on health education.
(Active Comparator)
A 6-month intervention, that consists of educational manuals on physical activity, diet and stress reduction and recommended 3 medical visits every 3 months for medical counseling and feedback using 5A (Ask, Advise, Assess, Assist, and Arrange) framework . These Metabolic syndrome care materials and provider documentation will be embedded in electronic medical record system, and will be accessible to medical providers by usual means. This enhanced usual care by participant's usual health care provider focuses on metabolic syndrome and lifestyle modifications to reduce the risk of chronic disease.
elm individual
ELM Individual arm participants will receive education materials on metabolic syndrome and diet, exercise, stress reduction recommendations. The participants will be recommended to follow these guidelines and discuss/seek support from their health care provider (visits at baseline, 3 and 6 months will be recommended.

Primary Outcomes

metabolic syndrome remission, defined as <3 of the 5 standard diagnostic criteria.
time frame: 6-month change

Secondary Outcomes

Nutrition intake
time frame: Baseline, and 6 months
time frame: At baseline and 6 months
International Physical Activity Questionnaire (IPAQ)
time frame: At baseline and 6 months
Perceived Stress Scale
time frame: At baseline, 3, and 6 months
time frame: At baseline, 3, and 6 months
time frame: At baseline and 6 months
Credibility and expectancies questionnaire (CEQ)
time frame: At baseline, 3, and 6 months
Vitality Index
time frame: At baseline, 3, and 6 months
Continuous metabolic syndrome score
time frame: At baseline, 3, and 6 months

Eligibility Criteria

Male or female participants from 18 years up to 72 years old.

Inclusion Criteria: - Men and women age 18-72 years (children and the elderly need age-specific lifestyle tailoring). - Able to walk 2 blocks (the patients should be able to engage in moderate intensity exercise). - Have preference for making lifestyle changes to treat MetS. - Able to participate in a lifestyle intervention for 6 months. - Meet at least 3 Metabolic syndrome diagnostic criteria: abdominal obesity (waist girth >102♂/88♀ cm), high blood pressure (≥130/85 mm Hg or treatment), triglyceridemia (≥150 mg/dL or fibrate therapy), low HDL-cholesterol (<40♂/50♀ mg/dL or niacin therapy) or fasting glucose ≥100 mg/dL (or pre-diabetes). Exclusion Criteria: - Substance abuse within the past 12 months: alcohol use, current daily smokers (self-report); and illicit drug use. - Weight loss, exceeding 10% of initial weight, in the past 6 months or current use of medications for weight loss, bowel resection surgery, bariatric surgery, eating disorder. - Other medical or behavioral limitations judged to interfere with study participation or the ability to follow study procedures (eg, scheduled surgery, travel plans or scheduling difficulties that do not permit full participation), limited English language, cognitive impairment, pregnancy, or psychiatric comorbidities (such as severe major depression, or psychotic disorders).

Additional Information

Official title A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome
Principal investigator Rasa Kazlauskaite, MD
Description The 3ELM ("Eat, Love, Move") study recruits 48 patients with MetS, and provides a 6-month intervention that aims to remit MetS by promoting the long-term adoption of healthier behaviors (diet, physical activity, stress reduction). Participants in 3ELM are randomly assigned to one of the study arms ("ELM Groups", "ELM Classes", "ELM Individual"); all of which receive some type of intervention in either group, class, or individual formats. The primary aim of this project is to pilot test the acceptability of each of the study arms and the outcome measures. The study also includes outcome assessments at 3 time points: at the start of the study, and at 3, and 6 months post baseline. All study participants will receive medical care (including metabolic syndrome care) from their regular medical doctors. Study staff will track participants' use of health care and wellness services during the study after obtaining participant permission to collect this data.
Trial information was received from ClinicalTrials.gov and was last updated in November 2014.
Information provided to ClinicalTrials.gov by Rush University Medical Center.